rs201009269
Variant summary
Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_021098.3(CACNA1H):c.1508G>A(p.Arg503His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000144 in 1,545,504 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R503C) has been classified as Likely benign.
Frequency
Consequence
NM_021098.3 missense
Scores
Clinical Significance
Conservation
Publications
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -13 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1H | ENST00000348261.11 | c.1508G>A | p.Arg503His | missense_variant | Exon 9 of 35 | 1 | NM_021098.3 | ENSP00000334198.7 | ||
| CACNA1H | ENST00000569107.6 | c.1508G>A | p.Arg503His | missense_variant | Exon 9 of 34 | 1 | ENSP00000454990.2 | |||
| CACNA1H | ENST00000711493.1 | c.1508G>A | p.Arg503His | missense_variant | Exon 9 of 34 | ENSP00000518778.1 | ||||
| CACNA1H | ENST00000565831.7 | c.1508G>A | p.Arg503His | missense_variant | Exon 9 of 34 | 1 | ENSP00000455840.1 | |||
| CACNA1H | ENST00000711450.1 | c.1508G>A | p.Arg503His | missense_variant | Exon 9 of 35 | ENSP00000518762.1 | ||||
| CACNA1H | ENST00000564231.6 | c.1508G>A | p.Arg503His | missense_variant | Exon 9 of 35 | 1 | ENSP00000457555.2 | |||
| CACNA1H | ENST00000638323.1 | c.1469G>A | p.Arg490His | missense_variant | Exon 9 of 35 | 5 | ENSP00000492267.1 | |||
| CACNA1H | ENST00000562079.6 | c.1508G>A | p.Arg503His | missense_variant | Exon 9 of 34 | 1 | ENSP00000454581.2 | |||
| CACNA1H | ENST00000711438.1 | c.1469G>A | p.Arg490His | missense_variant | Exon 9 of 34 | ENSP00000518754.1 | ||||
| CACNA1H | ENST00000711482.1 | c.1508G>A | p.Arg503His | missense_variant | Exon 9 of 36 | ENSP00000518771.1 | ||||
| CACNA1H | ENST00000711485.1 | c.1508G>A | p.Arg503His | missense_variant | Exon 9 of 35 | ENSP00000518774.1 | ||||
| CACNA1H | ENST00000711455.1 | c.1508G>A | p.Arg503His | missense_variant | Exon 9 of 36 | ENSP00000518768.1 | ||||
| CACNA1H | ENST00000711483.1 | c.1508G>A | p.Arg503His | missense_variant | Exon 9 of 35 | ENSP00000518772.1 | ||||
| CACNA1H | ENST00000711456.1 | c.1508G>A | p.Arg503His | missense_variant | Exon 9 of 34 | ENSP00000518769.1 | ||||
| CACNA1H | ENST00000621827.2 | n.1508G>A | non_coding_transcript_exon_variant | Exon 9 of 37 | 6 | ENSP00000518766.1 | ||||
| CACNA1H | ENST00000637236.3 | n.1508G>A | non_coding_transcript_exon_variant | Exon 9 of 34 | 5 | ENSP00000492650.2 | ||||
| CACNA1H | ENST00000639478.1 | n.1508G>A | non_coding_transcript_exon_variant | Exon 9 of 35 | 5 | ENSP00000491945.1 | ||||
| CACNA1H | ENST00000711442.1 | n.*955G>A | non_coding_transcript_exon_variant | Exon 8 of 34 | ENSP00000518758.1 | |||||
| CACNA1H | ENST00000711448.1 | n.1508G>A | non_coding_transcript_exon_variant | Exon 9 of 36 | ENSP00000518760.1 | |||||
| CACNA1H | ENST00000711449.1 | n.1508G>A | non_coding_transcript_exon_variant | Exon 9 of 35 | ENSP00000518761.1 | |||||
| CACNA1H | ENST00000711451.1 | n.1508G>A | non_coding_transcript_exon_variant | Exon 9 of 36 | ENSP00000518763.1 | |||||
| CACNA1H | ENST00000711452.1 | n.1508G>A | non_coding_transcript_exon_variant | Exon 9 of 36 | ENSP00000518764.1 | |||||
| CACNA1H | ENST00000711453.1 | n.1508G>A | non_coding_transcript_exon_variant | Exon 9 of 36 | ENSP00000518765.1 | |||||
| CACNA1H | ENST00000711484.1 | n.1508G>A | non_coding_transcript_exon_variant | Exon 9 of 35 | ENSP00000518773.1 | |||||
| CACNA1H | ENST00000711486.1 | n.1508G>A | non_coding_transcript_exon_variant | Exon 9 of 37 | ENSP00000518775.1 | |||||
| CACNA1H | ENST00000711487.1 | n.1508G>A | non_coding_transcript_exon_variant | Exon 9 of 36 | ENSP00000518776.1 | |||||
| CACNA1H | ENST00000711488.1 | n.1508G>A | non_coding_transcript_exon_variant | Exon 9 of 35 | ENSP00000518777.1 | |||||
| CACNA1H | ENST00000711442.1 | n.*955G>A | 3_prime_UTR_variant | Exon 8 of 34 | ENSP00000518758.1 | |||||
| CACNA1H | ENST00000640028.1 | n.1385+123G>A | intron_variant | Intron 9 of 34 | 5 | ENSP00000491488.1 |
Frequencies
GnomAD3 genomes AF: 0.000434 AC: 66AN: 152172Hom.: 0 Cov.: 34 show subpopulations
GnomAD2 exomes AF: 0.0000844 AC: 12AN: 142242 AF XY: 0.0000261 show subpopulations
GnomAD4 exome AF: 0.000112 AC: 156AN: 1393216Hom.: 1 Cov.: 36 AF XY: 0.0000976 AC XY: 67AN XY: 686594 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000433 AC: 66AN: 152288Hom.: 0 Cov.: 34 AF XY: 0.000349 AC XY: 26AN XY: 74466 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Epilepsy, childhood absence, susceptibility to, 6;C4310756:Hyperaldosteronism, familial, type IV Uncertain:1
CACNA1H NM_021098.2 exon 9 p.Arg503His (c.1508G>A): This variant has not been reported in the literature but is present in 0.1% (16/15288) of African alleles in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/16-1251958-G-A). This variant is present in ClinVar (Variation ID:460048). Evolutionary conservation and computational predictive tools for this variant are unclear. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. -
Inborn genetic diseases Uncertain:1
The c.1508G>A (p.R503H) alteration is located in exon 9 (coding exon 8) of the CACNA1H gene. This alteration results from a G to A substitution at nucleotide position 1508, causing the arginine (R) at amino acid position 503 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 35668055) -
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at